Urinary excretion of three nucleic acid oxidation adducts and isoprostane F 2 measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers

By Harman S.M.   Liang L.   Tsitouras P.D.   Gucciardo F.   Heward C.B.   Reaven P.D.   Ping W.   Ahmed A.   Cutler R.G.  

Free Radical Biology and Medicine, Vol. 35, Iss. 10, 2003-11 ,pp. : 1301-1309

Elsevier

Access to resources Recommend Favorite

Changes in urinary dinor dihydro F2-isoprostane metabolite concentrations, a marker of oxidative stress, during and following asthma exacerbations

By Wu Pingsheng   Roberts Lyman J.   Shintani Ayumi K.   Sheller James R.   Minton Patricia A.   Higgins Stanley B.   Hartert Tina V.  

Free Radical Research, Vol. 41, Iss. 9, 2007-01 ,pp. : 956-962

Informa Healthcare

Access to resources Recommend Favorite

Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease

By Ren Yuan   Deng Fengjun   Zhu Hang   Wan Weiren   Ye Jufeng   Luo Bingde  

Molecular Biology Reports, Vol. 38, Iss. 2, 2011-02 ,pp. : 879-886

Springer Publishing Company

Access to resources Recommend Favorite

Quantification of the Major Urinary Metabolite of 15-F_2t-Isoprostane (8-iso-PGF_2α) by a Stable Isotope Dilution Mass Spectrometric Assay

By Morrow J.D.   Zackert W.E.   Yang J.P.   Kurhts E.H.   Callewaert D.   Dworski R.   Kanai K.   Taber D.   Moore K.   Oates J.A.   Roberts L.J.  

Analytical Biochemistry, Vol. 269, Iss. 2, 1999-05 ,pp. : 326-331

Elsevier

Access to resources Recommend Favorite

Role of Cytokines in the Pathogenesis of Non-Alcoholic Fatty Liver Disease

By Das Subir  

Indian Journal of Clinical Biochemistry, Vol. 26, Iss. 2, 2011-04 ,pp. : 202-209

Springer Publishing Company

Access to resources Recommend Favorite